|
Bonadonna, Gianni; Valagussa, Pinuccia; Veronesi, Umberto (2008) Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. J Clin Oncol 26:342-4
|
|
Bonadonna, Gianni; Moliterni, Angela; Zambetti, Milvia et al. (2005) 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 330:217
|
|
Bonadonna, Gianni; Zambetti, Milvia; Moliterni, Angela et al. (2004) Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer. J Clin Oncol 22:1614-20
|
|
Bonadonna, G; Zambetti, M; Valagussa, P (1995) Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA 273:542-7
|
|
Zambetti, M; Bonadonna, G; Valagussa, P et al. (1992) Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients. J Natl Cancer Inst Monogr :77-83
|
|
Moliterni, A; Bonadonna, G; Valagussa, P et al. (1991) Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes. J Clin Oncol 9:1124-30
|
|
Buzzoni, R; Bonadonna, G; Valagussa, P et al. (1991) Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin Oncol 9:2134-40
|
|
Bonadonna, G; Valagussa, P (1989) Systemic therapy in resectable breast cancer. Hematol Oncol Clin North Am 3:727-42
|
|
Bonadonna, G; Valagussa, P (1989) Role of chemotherapy in stage I breast cancer. Important Adv Oncol :151-60
|
|
Bonadonna, G; Zambetti, M; Valagussa, P (1989) Adjuvant chemotherapy for node-negative breast cancer patients. Recent Results Cancer Res 115:175-9
|
Showing the most recent 10 out of 17 publications
